1.
Shaw K, Amstutz U, Castro-Pastrana L, Loo TT, Ross CJ, Ito S, Rieder MJ, Maher M, MacLeod S, Koren G, Hayden MR, Carleton BC. PHARMACOGENOMIC INVESTIGATION OF ADVERSE DRUG REACTIONS (ADRS): THE ADR PRIORITIZATION TOOL, APT. J Popl Ther Clin Pharmacol [Internet]. 2018 Nov. 22 [cited 2022 Sep. 27];20(2). Available from: https://www.jptcp.com/index.php/jptcp/article/view/381